Cardioresearch – Hellenic Cardiovasular Research Society-http://www.cardioresearch.gr

Cardioresearch – Hellenic Cardiovasular Research Society

Time 2022-10-19 08:26:16

Web Name: Cardioresearch – Hellenic Cardiovasular Research Society

WebSite: http://www.cardioresearch.gr

ID:358371

Keywords:

Hellenic,Cardioresearch,Society,Research

Description:

Η Εταιρεία Δομή και ΣτόχοιΠεριοδικό & ΕκδόσειςΣυνέδριαCardioresearch TVΠαρουσίαση ΠεριστατικώνΕπικοινωνίαΕλληνικά Επώνυμες ΑπόψειςΔίκτυο Ιατρικής ΑκρίβειαςΕρευνητικά ΠρογράμματαΕνδιαφέροντα ΝέαΔιεθνή Web NewsESC NewsResearch ConsortiaPersons & CareersΚοινότητες Ελληνική ΔιασποράΑνθρωπογεωγραφία ΚλινικώνΠροϊόντα ΦαρμακευτικάΒιοτεχνολογικάΨηφιακάBlue Skies Management & LeadershipDisruptive TechnologiesEconomicsHealth PoliciesTrends

EFFECTS OF TELEMEDICINE

THE CASE OF HEART FAILURE

Η Τηλεϊατρική, telemonitoring καιteleconsultation
αποδεικνύεται χρήσιμη στους ασθενείς με
καρδιακή ανεπάρκεια. The Lancet DH September, 2022

HEART VESSELS & STROKE

12-14 MΑΙΟΥ 2023

ΚΑΛΑΜΑΤΑ
ΞΕΝΟΔΟΧΕΙΟ FILOXENIA

ΕΛΛΗΝΙΚΑ ΝΟΣΟΚΟΜΕΙΑ

ΚΑΡΔΙΟΛΟΓΙΚΕΣ ΚΛΙΝΙΚΕΣ

Στοιχεία νοσηλευόμενων
εβδομηντάρηδες, καπνιστές
και ανεμβολίαστοι..

TAVI THROMBOSIS

LEAFLET SUBCLINICAL THROMBOSIS

Υπολογίζεται ότι 10%- 15%
των ασθενών με TAVI παρουσιάζουν
ασυμπτωματική θρόμβωση γλωχίνων...

AORTIC STENOSIS AND TAVI

USA: 50% IN YOUNGER PATIENTS

Ασθενείς με σοβαρή αορτική στένωση
ηλικίας < 65 ετών, στις ΗΠΑ, φαίνεται
να αντιμετωπίζονται με TAVI...

PASCAL vs MITRAL CLIP

HEAD TO HEAD COMPARISON

Pascal non-inferior to Mitral Clip
in degenerative MR patients.
Tα νέα από το TCC/Βοστώνη...

EMPAGLIFLOZIN ΙN ACUTE MI

EFFECTS IN PATIENTS POST MI

Βρέθηκε, ότι η χρήση Empagliflozin (10mg/ημερησίως)
για 26 εβδομάδες μετά από
οξύ έμφραγμα μυοκαρδίου...

PANTHER META-ANALYSIS

CAD: P2YI2 instead aspirin

Clopidogrel or Ticagrelor μπορεί, να είναι καλύτερη
επιλογή από την ασπιρίνη για αντιαιμοπεταλιακη
μονοθεραπεία, σε ασθενείς με στεφανιαία νοσο.

ESC CARDIOVASCULAR REALITIES 2022

Η Κοινότητα της Cardiοresearch

Εγγραφείτε δωρεάν μέλη and enjoy the benefits.

Industry Lounge

Παρουσιάζονται τρισδιάστατα (3D) περίπτερα φαρμακευτικών εταιρειών και εταιρειών βιοτεχνολογίας. Επίσης, παρουσιάζονται συνοπτικά θέματα που συνδέονται με τα εκτεθειμένα προϊόντα.

Η σελίδα είναι επισκέψιμη μόνο για γιατρούς. Παρακαλούμε κάντε εγγραφή.

Περισσότερα

Heart
Vessels & Brain

The cardioresearch journal

Δείτε τα τεύχη

Case Presentations

Παρουσίαση ενδιαφέροντων περιστατικών καρδιοαγγειακής ιατρικής.

Περισσότερα

Digital Health & Innovation

Παρουσίαση ελληνικών και διεθνών επιστημονικών εκδηλώσεων καρδιοαγγειακής ιατρικής.

Περισσότερα

Cardioresearch
TV

Μια συλλογή υψηλής ποιότητας επιστημονικών video.

Περισσότερα

Cardio Map
Greece

Περισσότερα

Νέα Τεχνολογικά
Προϊόντα

Περισσότερα

Τελευταία Νέα - Latest news

ΌλαStrokeDigital HealthImagingHeart FailureArrhythmias

Plaque histology and myocardial disease in sudden coronary death: the Fingesture study

Sudden cardiac death (SCD) accounts for ∼50% of total cardiovascular mortality and 10–20% of all deaths.1 Most of the SCDs (70–80%) are caused by coronary artery disease (CAD), whereas non-ischaemic myocardial diseases account for approximately one-fifth of the cases, and the minority is caused by other cardiac conditions (e.g. primary arrhythmia syndromes, valve diseases, or myocarditis).2,3 Although […]

Περισσότερα

Reconsidering safety and reducing barriers to MRI in patients with cardiac implantable electronic devices

Non-magnetic resonance imaging (MRI) conditional devices, leads, and abandoned leads traditionally represent a contraindication to MRI. Patients with MRI-conditional devices can safely undergo MRI if pre-defined device manufacturer steps are followed and met prior to and after performing MRI. Bhuva et al.4 provided data in support of a new contemporary approach in which patients with […]

Περισσότερα

How delivering cardiopulmonary resuscitation and basic life support skills training through places of worship can help save lives and address health inequalities

Early delivery of high-quality cardiopulmonary resuscitation (CPR) and rapid defibrillation strengthen the initial links of the chain of survival and can help improve out-of-hospital cardiac arrest (OHCA) outcomes. However, health inequalities exist in OHCA survival at regional and global levels, which reduces the chances of survival, with disproportionately lower CPR delivery rates seen in areas […]

Περισσότερα

High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making

Perioperative myocardial injury evidenced by cardiac biomarker elevation is common after cardiac surgery.1,2 The fourth universal definition of myocardial infarction (UDMI)2 defines perioperative or Type 5 myocardial infarction as an elevation of cardiac troponin (cTn) of 10× the 99th percentile upper reference limit (URL) combined with (i) new pathological Q waves on electrocardiogram (ECG), (ii) flow-limiting angiographic […]

Περισσότερα

The COVID-19 pandemic and heart failure: lessons from GUIDE-HF

The coronavirus disease 2019 (COVID-19) pandemic has led to major disruption in most aspects of human activity, including clinical trials. Normal social and professional interactions were severely limited, particularly during ‘lockdowns’. Attempting to mitigate the effects of the pandemic on clinical trials for conditions other than COVID-19, regulatory authorities, including the European Medicines Agency (EMA) […]

Περισσότερα

Long-term results of first-generation S-ICD systems: strong from the start and through the threats of time

The advent of the subcutaneous implantable cardioverter defibrillator (S-ICD) in clinical practice was meant to provide the well-established traditional transvenous implantable cardioverter defibrillator (TV-ICD) with potentially advantageous solutions. Among them were an easier implantation technique, a simpler algorithm for life-threatening event detection only, and no need for placement of ICD components in the heart and […]

Περισσότερα

Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study

There is currently no consensus on whether atrial fibrillation (AF) patients at low risk for stroke (one non-sex-related CHA2DS2-VASc point) should be treated with an oral anticoagulant. We conducted a multi-country cohort study in Sweden, Denmark, Norway, and Scotland. In total, 59 076 patients diagnosed with AF at low stroke risk were included. We assessed the […]

Περισσότερα

Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes

Atrial fibrillation (AF) has heterogeneous patterns of presentation concerning symptoms, duration of episodes, AF burden, and the tendency to progress towards the terminal step of permanent AF. AF is associated with a risk of stroke/thromboembolism traditionally considered dependent on patient-level risk factors rather than AF type, AF burden, or other characterizations. However, the time spent […]

Περισσότερα

Novel Technology Could Prevent Repeat Operations to Replace a Faulty Bioprosthetic Heart Valve

March 2, 2022 – An international study led by a researcher from Tel Aviv University offers a novel technology that can assist many patients implanted with bioprosthetic heart valve by avoiding additional complicated replacement surgery. Many heart patients implanted with such valves are forced to replace it ten years later due to calcification of valve tissue. The […]

Περισσότερα

European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of Cardiology

First published: 27 January 2022 Guideline-recommended therapies for heart failure (HF), particularly for HF with reduced ejection fraction, reduce morbidity and mortality.1 Yet observational data show geographic variation in their application in clinical practice.2–6 This disconnect between the development and the implementation of new healthcare technologies, the so-called ‘second translational gap’,7 calls for new initiatives which may […]

Περισσότερα

Ventricular fibrillation: combined myocardial substrate and Purkinje ablation

European Heart Journal, ehab912, Published: 09 February 2022 Since the earliest documented accounts of ventricular fibrillation (VF) >3000 years ago,1 the mechanisms responsible have been the source of ongoing debate. During the early part of the last century, both focal and re-entrant mechanisms were proposed, and more recently the re-entry mechanisms have polarized into the multiple […]

Περισσότερα

The year in cardiovascular medicine 2021: interventional cardiology

European Heart Journal, ehab884, Published: 03 January 2022 Since last year’s report in the European Heart Journal, we have witnessed substantial progress in all aspects of interventional cardiology. Of note, the practice of interventional cardiology took place amidst successive waves of the COVID-19 pandemic, which continues to be a major burden for all healthcare professionals around […]

Περισσότερα

Point-of-care screening for heart failure with reduced ejection fraction using artificial intelligence during ECG-enabled stethoscope examination in London, UK: a prospective, observational, multicentre study

The Lancet, Published:January 05, 2022DOI:-7500(21)00256-9 Most patients who have heart failure with a reduced ejection fraction, when left ventricular ejection fraction (LVEF) is 40% or lower, are diagnosed in hospital. This is despite previous presentations to primary care with symptoms. We aimed to test an artificial intelligence (AI) algorithm applied to a single-lead ECG, recorded […]

Περισσότερα

Neuroscientific therapies for atrial fibrillation

Cardiovascular Research, Volume 117, Issue 7, 15 June 2021, Pages 1732- 1745, Published: 14 May 2021 The cardiac autonomic nervous system (ANS) plays an integral role in normal cardiac physiology as well as in disease states that cause cardiac arrhythmias. The cardiac ANS, comprised of a complex neural hierarchy in a nested series of […]

Περισσότερα

Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology

European Heart Journal, ehab834, Published: 07 December 2021 A proposed conceptual framework for understanding atrial disease. Subclinical atrial disease develops under the effect of stressors such as aging, cardio-metabolic risk factors and diseases, and genetic predisposition that activate pathogenic mechanisms, such as inflammation, endothelial and microvascular dysfunction, fibrosis, hypercoagulability and atrial stretch that in turn […]

Περισσότερα

Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial

European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4111–4122, Published: 29 August 2021 Digital therapeutics is a new approach to facilitate the non-pharmacological treatment of hypertension using software programmes such as smartphone applications and/or device algorithms. Based on promising findings from a small pilot trial, the HERB Digital Hypertension 1 (HERB-DH1) pivotal […]

Περισσότερα

Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study

European Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4126–4137, Published: 16 July 2021 Persistence with direct oral anticoagulants (DOACs) has become a concern in non-valvular atrial fibrillation (NVAF) patients, but whether this affects prognosis is rarely studied. We investigated the persistence with oral anticoagulants (OACs) and its association with prognosis among a […]

Περισσότερα

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

EP Europace, Volume 23, Issue 10, October 2021, Pages 1612–1676, Published: 25 April 2021 Non-vitamin K antagonist oral anticoagulants (NOACs) are considered by atrial fibrillation (AF) guidelines world-wide as the preferred choice of anticoagulants to prevent stroke in patients with AF.1–4 The term NOAC has been used for many years, is used by the current European […]

Περισσότερα

Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study

European Heart Journal, ehab703, Published: 07 October 2021 The SYNTAX II study evaluated the impact of advances in percutaneous coronary intervention (PCI), integrated into a single revascularization strategy, on outcomes of patients with de novo three-vessel disease. The study employed decision-making utilizing the SYNTAX score II, use of coronary physiology, thin-strut biodegradable polymer drug-eluting stents, intravascular […]

Περισσότερα

Microvascular angina: quo tendimus?

European Heart Journal, ehab534, Published: 04 September 2021 Up to 40% of patients undergoing investigation for angina pectoris have no evidence of significant epicardial coronary disease by either elective computed tomography coronary angiography or invasive cardiac catheterization. Myocardial ischaemia can be detected in a large proportion of these patients. There is a wide spectrum of […]

Περισσότερα

Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study

European Heart Journal, Volume 42, Issue 29, 1 August 2021, Pages 2816 2823, The aim of this study was to investigate the causal effects between atrial fibrillation (AF) and kidney function. We performed a bidirectional summary-level Mendelian randomization (MR) analysis implementing the results from a large-scale genome-wide association study for estimated glomerular filtration rate […]

Περισσότερα

Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data

European Heart Journal, ehab504, Published: 02 August 2021 Data suggest that women have worse outcomes than men after coronary artery bypass grafting (CABG), but results have been inconsistent across studies. Due to the large differences in baseline characteristics between sexes, suboptimal risk adjustment due to low-quality data may be the reason for the observed differences. […]

Περισσότερα

Mavacamten boosts quality of life in patients with hypertrophic cardiomyopathy

Publish date: June 4, 2021 Of patients with symptomatic, obstructive hypertrophic cardiomyopathy treated with the investigational oral agent mavacamten, more than twice as many, compared with placebo, had a very large improvement from baseline in their summary quality of life score after 30 weeks of treatment in a pivotal trial with 194 patients evaluable for this […]

Περισσότερα

PHOTO GALLERY: How COVID-19 Appears on Medical Imaging

MAY 27, 2021 | DAVE FORNELL, EDITOR The photo gallery below shows the variety of radiological presentations of COVID-19 (SARS-CoV-2) in medical imaging, including computed tomography (CT), radiograph X-rays, ultrasound, echocardiograms and magnetic resonance imaging (MRI). The radiology images show examples of typical COVID pneumonia in the lungs and the numerous complications the virus causes in the body in multiple […]

Περισσότερα

Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke

May 15, 2021 DOI: 10.1056/NEJMoa2101897 Surgical occlusion of the left atrial appendage has been hypothesized to prevent ischemic stroke in patients with atrial fibrillation, but this has not been proved. The procedure can be performed during cardiac surgery undertaken for other reasons. We conducted a multicenter, randomized trial involving participants with atrial fibrillation and a […]

Περισσότερα

Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction

May 16, 2021 DOI: 10.1056/NEJMoa2104650 In patients with ST-elevation myocardial infarction (STEMI) who have multivessel disease, percutaneous coronary intervention (PCI) for nonculprit lesions (complete revascularization) is superior to treatment of the culprit lesion alone. However, whether complete revascularization that is guided by fractional flow reserve (FFR) is superior to an angiography-guided procedure is unclear. In […]

Περισσότερα

Valve Academic Research Consortium 3: updated endpoint definitions

European Heart Journal, Volume 42, Issue 19, 14 May 2021, Pages 1825 1857, Published: 19 April 2021 The Valve Academic Research Consortium (VARC), founded in 2010, was intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these endpoints for transcatheter and surgical aortic valve clinical trials. Rapid evolution of the field, […]

Περισσότερα

Left ventricular segmental strain and the prediction of cancer therapy-related cardiac dysfunction

European Heart Journal – Cardiovascular Imaging, Volume 22, Issue 4, April 2021, Pages 418-426, Published: 18 November 2020 In a cohort of 237 women with breast cancer receiving doxorubicin with or without trastuzumab, 1151 echocardiograms were prospectively acquired over a median (Q1–Q3) of 7 (2–24) months. LV ejection fraction (LVEF) and 36 segmental strain […]

Περισσότερα

Posterior Left Atrial Adipose Tissue Attenuation Assessed by Computed Tomography and Recurrence of Atrial Fibrillation After Catheter Ablation

Originally published15 Mar 2021 Circulation: Arrhythmia and Electrophysiology. 2021;14 Atrial fibrillation (AF) recurrence following catheter ablation remains high. Recent studies have shown a relation between epicardial adipose tissue and AF. epicardial adipose tissue secretes several proinflammatory and anti-inflammatory adipokines that directly interact with the adjacent myocardium. The aim of the current study was […]

Περισσότερα

Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy: insights from TRED‐HF

First published: 22 November 2020 To characterize adverse ventricular remodelling after withdrawing therapy in recovered dilated cardiomyopathy (DCM). TRED‐HF was a randomized controlled trial with a follow‐on single‐arm cross‐over phase that examined the safety and feasibility of therapy withdrawal in patients with recovered DCM over 6 months. The primary endpoint was relapse of heart failure […]

Περισσότερα

Cardiology training using technology

European Heart Journal, Volume 42, Issue 15, 14 April 2021, Pages 1453-1455 Published: 28 December 2020 The coronavirus disease-2019 (COVID-19) pandemic has had an unparalleled impact on cardiology training worldwide. In the next few sections, we highlight several foundational considerations for building a successful technology-enabled model in the new normal for cardiology training. […]

Περισσότερα

Cryoblation as first-line treatment of new-onset atrial fibrillation?

European Heart Journal, Volume 42, Issue 16, 21 April 2021, Pages 1543-1544, Published: 24 March 2021 The European Society of Cardiology Guidelines for the diagnosis and management of AF3 recommend (Class IA) rhythm control therapy for symptom and quality of life improvement in symptomatic patients with AF. However, for rhythm control, catheter ablation is […]

Περισσότερα

Immersive 3D virtual reality imaging in planning minimally invasive and complex adult cardiac surgery

European Heart Journal – Digital Health, Volume 1, Issue 1, November 2020, Pages 62-70, Published: 23 November 2020 Increased complexity in cardiac surgery over the last decades necessitates more precise preoperative planning to minimize operating time, to limit the risk of complications during surgery and to aim for the best possible patient outcome. Novel, […]

Περισσότερα

New Class of Radially Adjustable Stentrievers for Acute Ischemic Stroke

Originally published19 Mar 2021 Stroke. 2021;52:1534–1544 The Tigertriever is a novel, radially adjustable, fully visible, stentriever that permits the operator to align radial expansion with target vessel diameters. This multicenter trial compared the Tigertriever’s effectiveness and safety compared with established stent retrievers. Single arm, prospective, multicenter trial comparing the Tigertriever to efficacy and […]

ΠερισσότεραLoad more

Congresses
& Events

Forums of Excellence
In Cardiovascular Medicine

Περισσότερα

Προτεινόμενα πρόσφατα επιστημονικά άρθρα

14 Οκτωβρίου, 2022

Explainability and artificial intelligence in medicine

VOLUME 4, ISSUE 4, E214-E215, APRIL 01, 2022

Explainability and artificial intelligence in medicine

VOLUME 4, ISSUE 4, E214-E215, APRIL 01, 2022

14 Οκτωβρίου, 2022

Advancing digital health applications: priorities for innovation in real-world evidence generation

VOLUME 4, ISSUE 3, E200-E206, MARCH 01, 2022

Advancing digital health applications: priorities for innovation in real-world evidence generation

VOLUME 4, ISSUE 3, E200-E206, MARCH 01, 2022

14 Οκτωβρίου, 2022

Personalized medicine and the power of electronic health records

Cell. 2019 Mar 21; 177(1): 58–69.

Personalized medicine and the power of electronic health records

Cell. 2019 Mar 21; 177(1): 58–69.

1 Σεπτεμβρίου, 2022

ESC 2022: Risk score predicts mortality for AF patients after TAVI

Risk score predicts mortality for AF patients after TAVI

ESC 2022: Risk score predicts mortality for AF patients after TAVI

Risk score predicts mortality for AF patients after TAVI

1 Σεπτεμβρίου, 2022

New ESC Cardio-Oncology Guideline Aims to Reduce Cardiotoxicity

New ESC Cardio-Oncology Guideline Aims to Reduce Cardiotoxicity – Medscape – Aug 31, 2022.

New ESC Cardio-Oncology Guideline Aims to Reduce Cardiotoxicity

New ESC Cardio-Oncology Guideline Aims to Reduce Cardiotoxicity – Medscape – Aug 31, 2022.

4 Ιουλίου, 2022

Artificial intelligence opportunities in cardio-oncology: Overview with spotlight on electrocardiography

Am Heart J Plus. 2022 Mar;15:100129. doi: 10.1016/j.ahjo.2022.100129. Epub 2022 Apr 1.

Artificial intelligence opportunities in cardio-oncology: Overview with spotlight on electrocardiography

Am Heart J Plus. 2022 Mar;15:100129. doi: 10.1016/j.ahjo.2022.100129. Epub 2022 Apr 1.

4 Ιουλίου, 2022

Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study

JACC Journals › JACC › Archives › Vol. 80 No. 1

Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study

JACC Journals › JACC › Archives › Vol. 80 No. 1

5 Μαΐου, 2022

Artificially Intelligent Interpretation of Stress Echocardiography: The Future Is Now

J Am Coll Cardiol Img. 2022 May, 15 (5) 728–730

Artificially Intelligent Interpretation of Stress Echocardiography: The Future Is Now

J Am Coll Cardiol Img. 2022 May, 15 (5) 728–730

9 Μαρτίου, 2022

Same-day discharge for catheter ablation of atrial fibrillation deemed safe and feasible

Cardiac Rhythm News 1st March 2022

Same-day discharge for catheter ablation of atrial fibrillation deemed safe and feasible

Cardiac Rhythm News 1st March 2022

24 Φεβρουαρίου, 2022

High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep Learning

JAMA Cardiol. Published online February 23, 2022. doi:10.1001/jamacardio.2021.6059

High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep Learning

JAMA Cardiol. Published online February 23, 2022. doi:10.1001/jamacardio.2021.6059

4 Φεβρουαρίου, 2022

Remote monitoring data from cardiac implantable electronic devices predicts all-cause mortality

EP Europace, Volume 24, Issue 2, February 2022, Pages 245–255, https://doi.org/10.1093/europace/euab160

Remote monitoring data from cardiac implantable electronic devices predicts all-cause mortality

EP Europace, Volume 24, Issue 2, February 2022, Pages 245–255, https://doi.org/10.1093/europace/euab160

28 Ιανουαρίου, 2022

The year in cardiovascular medicine 2021: interventional cardiology

European Heart Journal, ehab884, https://doi.org/10.1093/eurheartj/ehab884 Published: 03 January 2022

The year in cardiovascular medicine 2021: interventional cardiology

European Heart Journal, ehab884, https://doi.org/10.1093/eurheartj/ehab884 Published: 03 January 2022

18 Ιανουαρίου, 2022

Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction: a nationwide population-based study

The Lancet, VOLUME 4, ISSUE 1, E37-E45, JANUARY 01, 2022

Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction: a nationwide population-based study

The Lancet, VOLUME 4, ISSUE 1, E37-E45, JANUARY 01, 2022